The company focuses on the research and development, production, and sales of high-end sustained-release formulations such as osmotic pumps, pellet coatings, and skeleton tablets. It has passed four cGMP on-site inspections by the US FDA, and has achieved FDA "zero defect" certification twice. Multiple products have been produced and sold simultaneously in China and the United States.